ADO 0.00% 2.2¢ anteotech ltd

ado research, major re rate on the way, page-47

  1. 658 Posts.
    thanks fp and peff for that updated link.

    i would encourage holders to read this article

    http://irgnews.com/sites/default/themes/publisher/images/companies/CGNH/Beads/CGNH%20Magnetic%20Bead%20Market%20Opportunity.pdf

    talks bout magnetic beads, the market size specifically for beads, the industry leaders, how beads works and application for beads.

    some of the points from the above article that i would like to highlight:

    1.
    Several companies produce magnetic beads, both naked and finished product (linked to biological reagents). The top bead producers are Dynal, which was acquired by Invitrogen, Merck Estabor, Bang Laboratories, Seadyne and Qiagen.


    (2/5 of the top bead producers are using Mixngo to link beads to biological reagents.)



    2.
    Although the exact figures of the magnetic particles market size are hard to determine with high accuracy. A market research report calculated the market size of paramagnetic beads to range about $1 billion for immunoassays and molecular diagnostics. An independent research report (by Adventus Research Inc.) funded by National Research council has estimated the current market for magnetic beads for immunoassays and molecular diagnostics to be about $1 billion.


    this article should be from earlier this year if i m not mistaken. i hope it is a good read for all and happy new year in advance!

    this year we have 2deals with 2major bead producers, heres wishing we will have 2 deals with 2IVD major pharmas in 2011.



 
watchlist Created with Sketch. Add ADO (ASX) to my watchlist
(20min delay)
Last
2.2¢
Change
0.000(0.00%)
Mkt cap ! $54.30M
Open High Low Value Volume
2.1¢ 2.2¢ 2.1¢ $5.118K 235.0K

Buyers (Bids)

No. Vol. Price($)
1 54235 2.1¢
 

Sellers (Offers)

Price($) Vol. No.
2.2¢ 472615 5
View Market Depth
Last trade - 16.10pm 29/07/2024 (20 minute delay) ?
ADO (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.